SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS by Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M

“…American Society of Hematology…”

Elucidation of the EP defect in Diamond-Blackfan anemia by characterization and prospective isolation of human EPs. by Iskander, D, Psaila, B, Gerrard, G, Chaidos, A, Foong, H, Harrington, Y, Karnik, L, Roberts, I, de la Fuente, J, Karadimitris, A

“…American Society of Hematology…”

Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression by Silveira, DRA, Chatzikyriakou, P, Yavorska, O, Mackie, S, Hulks, R, Siejka-Zielinska, P, Corby, A, Smith, A, Brown, B, Metzner, M, Milne, TA, Penard-Lacronique, V, Song, C, Hasan, M, Thakurta, A, Vyas, P, Kriaucionis, S, Quek, L

“…American Society of Hematology…”

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up by Salisbury, R, Iotchkova, V, Jaafar, S, Morton, J, Sangha, G, Untiveros, P, Curry, N, Shapiro, S

“…American Society of Hematology…”

A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acut... by Vyas, P, Daver, N, Chao, M, Xing, G, Renard, C, Ramsingh, G, Wei, AH, Sallman, DA

“…American Society of Hematology…”

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO

“…American Society of Hematology…”

Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis by Lecomte, S, Devreux, J, de Streel, G, van Baren, N, Havelange, V, Schröder, D, Vaherto, N, Vanhaver, C, Vanderaa, C, Dupuis, N, Pecquet, C, Coulie, PG, Constantinescu, SN, Lucas, S

“…American Society of Hematology…”

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia by Stein, EM, DiNardo, CD, Pollyea, DA, Fathi, AT, Roboz, GJ, Altman, JK, Stone, RM, DeAngelo, DJ, Levine, RL, Flinn, IW, Kantarjian, HM, Collins, R, Patel, MR, Frankel, AE, Stein, A, Sekeres, MA, Swords, RT, Medeiros, BC, Willekens, C, Vyas, P, Tosolini, A, Xu, Q, Knight, RD, Yen, KE, Agresta, S, De Botton, S, Tallman, MS

“…American Society of Hematology…”

Degrading JAK2 in ALL by ruxolitinib-based PROTACs by Constantinescu, SN, Pecquet, C

“…American Society of Hematology…”

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the ra... by DiNardo, CD, Montesinos, P, Schuh, AC, Papayannidis, C, Vyas, P, Wei, AH, Zeidan, AM, Bluemmert, I, Yu, X, Hasan, M, Martin-Regueira, P, de Botton, S

“…American Society of Hematology…”

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome by Cruz Hernandez, D, Metzner, M, de Groot, AP, Usukhbayar, B, Elliott, N, Roberts, I, Vyas, P

“…American Society of Hematology…”

Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. by Lee, W, Malleret, B, Lau, Y, Mauduit, M, Fong, M, Cho, J, Suwanarusk, R, Zhang, R, Albrecht, L, Costa, F, Preiser, P, Mcgready, R, Renia, L, Nosten, F, Russell, B

“…American Society of Hematology…”

A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression by Badat, M, Davies, JOJ, Fisher, CA, Downes, DJ, Rose, A, Glenthøj, AB, van Beers, EJ, Harteveld, CL, Higgs, DR

“…American Society of Hematology…”

Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia by Winer, P, Muskens, IS, Walsh, KM, Vora, A, Moorman, AV, Wiemels, JL, Roberts, I, Roy, A, de Smith, AJ

“…American Society of Hematology…”

Epistasis between the haptoglobin common variant and α+thalassemia influences risk of severe malaria in Kenyan children by Atkinson, S, Uyoga, S, Nyatichi, E, Macharia, A, Nyutu, G, Ndila, C, Kwiatkowski, D, Rockett, K, Williams, T

“…American Society of Hematology…”

Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL by Paietta, E, Roberts, KG, Wang, V, Gu, Z, Buck, GAN, Pei, D, Cheng, C, Levine, RL, Abdel-Wahab, O, Cheng, Z, Wu, G, Qu, C, Shi, L, Pounds, S, Willman, CL, Harvey, R, Racevskis, J, Barinka, J, Zhang, Y, Dewald, GW, Ketterling, RP, Alejos, D, Lazarus, HM, Luger, SM, Foroni, L, Patel, B, Fielding, AK, Melnick, A, Marks, DI, Moorman, AV, Wiernik, PH, Rowe, JM, Tallman, MS, Goldstone, AH, Mullighan, CG, Litzow, MR

“…American Society of Hematology…”

CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies by Bueno, C, Barrena, S, Bataller, A, Ortiz-Maldonado, V, Elliott, N, O'Byrne, S, Wang, G, Rovira, M, Gutierrez-Agüera, F, Trincado, JL, Gonzalez, M, Morgades, M, Sorigué, M, Barcena, P, Zanetti, SR, Torrebadell, M, Vega-García, N, Rives, S, Mallo, M, Sole, F, Mead, AJ, Roberts, I, Thongjuea, S, Psaila, B, Juan, M, Delgado, J, Urbano-Ispizua, Á, Ribera, J-M, Orfao, A, Roy, A, Menéndez, P

“…American Society of Hematology…”

Variable cells with identical genetic codes by Babbs, C, Higgs, DR

“…American Society of Hematology…”

SCL/TAL1: a multifaceted regulator from blood development to disease by Porcher, C, Chagraoui, H, Kristiansen, M

“…American Society of Hematology…”

Natural killer T cells accelerate atherogenesis in mice by Nakai, Y, Iwabuchi, K, Fujii, S, Ishimori, N, Dashtsoodol, N, Watano, K, Mishima, T, Iwabuchi, C, Tanaka, S, Bezbradica, J, Nakayama, T, Taniguchi, M, Miyake, S, Yamamura, T, Kitabatake, A, Joyce, S, Van Kaer, L, Onoé, K

“…American Society of Hematology…”